Cart
GPCR/G Protein cholecystokinin

cholecystokinin

Cholecystokinin is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein.
Cat No. product name
T1052 Proglumide Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secre...
T2312 Loxiglumide Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
T6940 PHA767491 HCl PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM). It has ~20-fold selectivity against GSK3-β and CDK1/2, 50-fold selectivit...
TQ0062 Nastorazepide Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
T3352 XL413 XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the ...
T6735 XL413 hydrochloride XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 ...
T6206 PHA-767491 PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
T15759 Lintitript Lintitript is a highly potent, selective, orally active, competitive, and non-peptide cholecystokinin (CCK1) receptor antagonist (EC50: 6 nM and a Ki: 0.2 nM). ...
T11868 Lorglumide sodium salt Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist. 
Proglumide
T1052CAS 6620-60-6
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secre...
Loxiglumide
T2312CAS 107097-80-3
Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
PHA767491 HCl
T6940CAS 942425-68-5
PHA-767491 is an effective ATP-competitive dual Cdc7/CDK9 inhibitor (IC50: 10/34 nM). It has ~20-fold selectivity against GSK3-β and CDK1/2, 50-fold selectivit...
Nastorazepide
TQ0062CAS 209219-38-5
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
XL413
T3352CAS 1169558-38-6
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the ...
XL413 hydrochloride
T6735CAS 1169562-71-3
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. CDC7 kinase inhibitor BMS-863233 ...
PHA-767491
T6206CAS 845714-00-3
PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
Lintitript
T15759CAS 136381-85-6
Lintitript is a highly potent, selective, orally active, competitive, and non-peptide cholecystokinin (CCK1) receptor antagonist (EC50: 6 nM and a Ki: 0.2 nM). ...
Lorglumide sodium salt
T11868CAS 1021868-76-7
Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.